PROSTATE CANCER: Bone density testing—essential or extraneous?


    loading  Checking for direct PDF access through Ovid

Abstract

A recent study shows that recommended bone mineral testing is rarely performed in men with prostate cancer receiving androgen deprivation therapy. Although these patients are at increased risk of fragility fracture, the reported incidence, from prospective randomized trials, is low. As a result, bone density testing for these men requires careful consideration.

    loading  Loading Related Articles